Reported 374,069 shares, unchanged from the prior quarter.
Reported value -10.5%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-12-31 | 4843454 |
| 2023-03-31 | 5160040 |
| 2023-06-30 | 10811977 |
| 2023-09-30 | 11440241 |
| 2023-12-31 | 14065311 |
| 2024-03-31 | 15161119 |
| 2024-06-30 | 13479040 |
| 2024-09-30 | 14696251 |
| 2024-12-31 | 18960975 |
| 2025-03-31 | 14845785 |
| 2025-06-30 | 15838694 |
| 2025-09-30 | 19762480 |
| 2025-12-31 | 23749069 |
| 2026-03-31 | 23917972 |
| 2026-06-30 | 27359407 |
| 2026-09-30 | 24486557 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 374,069 | 0 (0.0%) | 8.47% | $24,486,557 | 2026-11-16 | |
| Q2 2026 | Unchanged | 374,069 | 0 (0.0%) | 7.55% | $27,359,407 | 2026-08-14 | |
| Q1 2026 | Added | 374,069 | +75,000 (25.1%) | 8.83% | $23,917,972 | 2026-05-15 | |
| Q4 2025 | Unchanged | 299,069 | 0 (0.0%) | 14.45% | $23,749,069 | 2026-02-17 | |
| Q3 2025 | Unchanged | 299,069 | 0 (0.0%) | 18.17% | $19,762,480 | 2025-11-14 | |
| Q2 2025 | Unchanged | 299,069 | 0 (0.0%) | 19.62% | $15,838,694 | 2025-08-12 | |
| Q1 2025 | Unchanged | 299,069 | 0 (0.0%) | 16.94% | $14,845,785 | 2025-05-15 | |
| Q4 2024 | Unchanged | 299,069 | 0 (0.0%) | 15.78% | $18,960,975 | 2025-02-14 | |
| Q3 2024 | Unchanged | 299,069 | 0 (0.0%) | 10.21% | $14,696,251 | 2024-11-14 | |
| Q2 2024 | Added | 299,069 | +55,556 (22.8%) | 8.61% | $13,479,040 | 2024-08-13 | |
| Q1 2024 | Unchanged | 243,513 | 0 (0.0%) | 14.23% | $15,161,119 | 2024-05-15 | |
| Q4 2023 | Unchanged | 243,513 | 0 (0.0%) | 19.16% | $14,065,311 | 2024-02-13 | |
| Q3 2023 | Unchanged | 243,513 | 0 (0.0%) | 18.25% | $11,440,241 | 2023-11-13 | |
| Q2 2023 | Unchanged | 243,513 | 0 (0.0%) | 7.9% | $10,811,977 | 2023-08-11 | |
| Q1 2023 | Unchanged | 243,513 | 0 (0.0%) | 3.81% | $5,160,040 | 2023-05-12 | |
| Q4 2022 | New | 243,513 | +243,513 (0.0%) | 3.76% | $4,843,454 | 2023-02-13 |
Who else reported the position
259 managers reported DISC MEDICINE INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Reduced | 4,803,145 | -91,328 | 0.01% | $314,413,870 | 16 qtrs |
| BlackRock Inc | Added | 2,532,863 | +64,964 | < 0.01% | $165,801,211 | 9 qtrs |
| RA CAPITAL MANAGEMENT L P | Unchanged | 2,450,221 | 0 | 1.61% | $160,391,467 | 7 qtrs |
| JPMorgan Chase & Co | Reduced | 1,812,170 | -63,625 | < 0.01% | $119,497,054 | 16 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Added | 1,756,490 | +15,139 | 0.02% | $114,979,835 | 14 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Reduced | 1,655,238 | -220,161 | 0.01% | $108,353,000 | 14 qtrs |
| Vestal Point Capital LP | Added | 1,635,000 | +85,000 | 2.77% | $107,027,100 | 6 qtrs |
| STATE STREET CORPORATION | Reduced | 1,405,446 | -243,390 | < 0.01% | $92,000,495 | 16 qtrs |
| Atlas Venture Life Science Advisors LLC | Reduced | 1,384,025 | -129,850 | 14.35% | $90,598,277 | 16 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 1,384,014 | +14,987 | < 0.01% | $90,597,556 | 3 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 374,069
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.